{"id":"W4399452838","doi":"10.1200/jco.2024.42.17_suppl.lba9516","title":"Phase III randomized trial evaluating tilsotolimod in combination with ipilimumab versus ipilimumab alone in patients with advanced refractory melanoma (ILLUMINATE 301).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ipilimumab; Medicine; Clinical endpoint; Internal medicine; Hazard ratio; Adverse effect; Melanoma; Refractory (planetary science); Oncology; Randomized controlled trial; Surgery; Immunotherapy; Gastroenterology; Confidence interval; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002271745,0.001460597,0.002920437,0.000371794,0.0004042302,0.001124289,0.001119002,0.001497883,0.00884203],"category_scores_gemma":[0.001883098,0.000725419,0.002007241,0.0004803176,0.0008841223,0.0008753939,0.0004455101,0.003271142,0.001488935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001143912,"about_ca_system_score_gemma":0.001375873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001606393,"about_ca_topic_score_gemma":0.003644404,"domain_scores_codex":[0.9993036,0.0004241864,0.00002916293,0.0001169918,0.00004630249,0.00007967719],"domain_scores_gemma":[0.9989513,0.0002578225,0.0002938136,0.00007114489,0.00007049047,0.0003554088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9816759,0.00308231,0.0005218752,0.0005548034,0.000968463,0.00003116192,0.00002869714,0.0003125554,0.001893777,0.00009227981,0.001472232,0.00936592],"study_design_scores_gemma":[0.9676531,0.02967506,0.001052564,0.00003119803,0.0003835933,0.00002649824,0.00001216678,0.0002549949,0.0001471287,0.00009832953,0.0006578979,0.000007522262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9546081,0.01241584,0.001486198,0.002321518,0.001870008,0.014105,0.005800317,0.000289776,0.007103335],"genre_scores_gemma":[0.9655316,0.004915914,0.00260318,0.003199301,0.0007487012,0.01148195,0.00446144,0.0000570811,0.0070009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00884203,"threshold_uncertainty_score":0.02957952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06765289190333494,"score_gpt":0.4578041428549777,"score_spread":0.3901512509516427,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}